- Home
- PBYI vs ECBK Comparison
PBYI vs ECBK Comparison
Compare PBYI & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- ECBK
- Stock Information
- Founded
- PBYI 2010
- ECBK 1919
- Country
- PBYI United States
- ECBK United States
- Employees
- PBYI N/A
- ECBK N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- ECBK Banks
- Sector
- PBYI Health Care
- ECBK Finance
- Exchange
- PBYI Nasdaq
- ECBK Nasdaq
- Market Cap
- PBYI 164.3M
- ECBK 151.0M
- IPO Year
- PBYI N/A
- ECBK N/A
- Fundamental
- Price
- PBYI $3.56
- ECBK $16.22
- Analyst Decision
- PBYI Strong Buy
- ECBK
- Analyst Count
- PBYI 1
- ECBK 0
- Target Price
- PBYI $7.00
- ECBK N/A
- AVG Volume (30 Days)
- PBYI 299.1K
- ECBK 67.3K
- Earning Date
- PBYI 07-31-2025
- ECBK 08-08-2025
- Dividend Yield
- PBYI N/A
- ECBK N/A
- EPS Growth
- PBYI 143.51
- ECBK 17.87
- EPS
- PBYI 0.77
- ECBK 0.57
- Revenue
- PBYI $232,709,000.00
- ECBK $26,906,000.00
- Revenue This Year
- PBYI N/A
- ECBK N/A
- Revenue Next Year
- PBYI N/A
- ECBK N/A
- P/E Ratio
- PBYI $4.64
- ECBK $28.60
- Revenue Growth
- PBYI 2.68
- ECBK 5.99
- 52 Week Low
- PBYI $2.23
- ECBK $12.50
- 52 Week High
- PBYI $4.13
- ECBK $16.99
- Technical
- Relative Strength Index (RSI)
- PBYI 56.71
- ECBK 63.48
- Support Level
- PBYI $3.49
- ECBK $14.82
- Resistance Level
- PBYI $3.65
- ECBK $16.25
- Average True Range (ATR)
- PBYI 0.13
- ECBK 0.37
- MACD
- PBYI 0.01
- ECBK 0.15
- Stochastic Oscillator
- PBYI 75.80
- ECBK 97.90
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About ECBK ECB Bancorp Inc.
ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.